ISTH 2019 Conference Review

In this review:

Investigational factor VIII therapy for VWD
PCC for FXa-inhibitor/vitamin K antagonist-induced intracranial bleeding
DOACs: perioperative major bleeding and ATE
LMWH for isolated symptomatic DVT
Recurrence risk after first symptomatic distal vs proximal DVT
Gene therapy for severe haemophilia A
Vena cava filters in severely injured patients
Rivaroxaban for acute VTE in children
Reduced dose of idarucizumab in dabigatran reversal
Thrombosis in antiphospholipid syndrome patients

Please login below to download this issue (PDF)